Clinical Trials of Ashwagandha (KSM-66 / Sensoril): Cortisol and Anxiety

Research and science

🌿 Clinical Trials of Ashwagandha (KSM-66 / Sensoril): Cortisol and Anxiety

What research shows about ashwagandha - let's look at the standardized forms and data

Ashwagandha is an adaptogen studied for stress and anxiety. Clinical trials often use the standardized forms KSM-66 and Sensoril. Let's look at what the data show.

Ashwagandha is studied for its effect on cortisol - the stress hormone. Let's look at the mechanism, forms and data.

Key idea: ashwagandha is studied for lowering cortisol and anxiety. KSM-66 and Sensoril are standardized forms used in trials. The data are promising, but the effect is moderate.

🌿 What is ashwagandha

Ashwagandha (Withania somnifera) is a plant used in Ayurveda. It is considered an adaptogen - a substance that helps adapt to stress.

Compounds: the active substances of ashwagandha are withanolides. They are linked to effects on stress and the nervous system.
Related topic: ashwagandha is one of the adaptogens. More in the article on adaptogens.

🧬 Mechanism

The mechanism of ashwagandha is linked to the stress axis.

Mechanism: ashwagandha is studied for its effect on the hypothalamic-pituitary-adrenal (HPA) axis. This may lower cortisol.
Nuance: the exact mechanisms need further research.

💊 KSM-66 and Sensoril

KSM-66 and Sensoril are standardized ashwagandha extracts used in trials.

FormFeature
KSM-66Root extract, withanolide standardization
SensorilRoot and leaf extract
Tip: standardized forms provide a predictable dose of active substances.

😰 Cortisol and stress

Ashwagandha is studied for its effect on cortisol and stress.

Data: some studies show lower cortisol with ashwagandha. This is linked to reduced stress.
Nuance: the effect is moderate and individual. Not for everyone.

📊 Trial data

What clinical trials show.

IndicatorWhat is shown
CortisolLower in several studies
AnxietyImproved scores
SleepImproved
Tip: most trials use KSM-66 or Sensoril at 300-600 mg/day.

⚠️ Limits

It is important to understand the limits of the data.

Limits: many studies are small and short. The effect is moderate and mixed.
Reality: ashwagandha is promising, but it does not replace anxiety treatment. With conditions - a doctor.

💡 What matters

How to sensibly approach ashwagandha.

1

Understand the data

Ashwagandha is studied for lowering cortisol and anxiety.

2

Choose the forms

KSM-66 and Sensoril are standardized forms from trials.

3

Follow the doses

In trials, usually 300-600 mg/day. Follow the instructions.

4

Consider contraindications

Ashwagandha may affect the thyroid and medications. Consult a doctor. More in the article on adaptogens.

Bottom line: ashwagandha is studied for lowering cortisol and anxiety. KSM-66 and Sensoril are standardized forms. The data are promising, but the effect is moderate. With anxiety - a comprehensive approach.
❓ Frequently asked questions
What is ashwagandha?

An adaptogen from Ayurveda. It is studied for effects on stress, cortisol and anxiety.

What are KSM-66 and Sensoril?

Standardized ashwagandha extracts used in clinical trials.

Does ashwagandha lower cortisol?

Some studies show lower cortisol. The effect is moderate.

Does it help with anxiety?

Several studies show improved anxiety scores. The data are mixed.

How much to take?

In trials, usually 300-600 mg of standardized extract per day.

Is ashwagandha safe?

At recommended doses usually yes. It may affect the thyroid and medications - a doctor.

Does it replace treatment?

No. With anxiety - a comprehensive approach and a doctor. Ashwagandha is support.

How does it work?

It affects the HPA axis and withanolides. It may lower cortisol.

Are there limits to the data?

Yes, many studies are small and short. The effect is moderate.

Who is it contraindicated for?

With thyroid issues, pregnancy, medications - a doctor's consultation.

Scientific Data on Lion's Mane: Stimulating NGF and BDNFCreatine Beyond Muscles: Effects on Cognitive Function in Older AdultsMelatonin as an Antioxidant and Oncoprotector: Laboratory and Clinical Data